Apr 20, 2017 - Nearly 90% of this biotech's sales could be at risk within the next two years.
Apr 25, 2017 - Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
Apr 17, 2017 - Shares of Incyte and Eli Lilly are reeling following the FDA's rejection of their once-daily rheumatoid arthritis pill.
Sep 29, 2017 - Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
Aug 31, 2015 - Bristol-Myers Squibb Company (BMY) announced that it has entered into a research collaboration and license agreement with QIMR Berghofer Medical Research Institute.
Aug 25, 2015 - Exelixis, Inc. (EXEL) announced that its oncology drug, Cometriq has received Breakthrough Therapy designation from the FDA.
Aug 27, 2015 - Oncolytics Biotech (ONCY) completed enrolling patients in a phase II study on Reolysin for the treatment of non-small cell lung cancer.
Aug 24, 2015 - Vital Therapies, Inc. (VTL) announced negative top-line data from the phase III VTI-208 study evaluating the ELAD System in patients with alcohol-induced liver decompensation.
Sep 18, 2015 - 3M Safety and Graphics Business Group, a part of 3M Company (MMM), recently announced a minority equity investment in StrongArm Technologies Inc., - a company that designs innovative safety products.
Apr 26, 2016 - Eli Lilly & Co. (NYSE:LLY)Q1 2016 Earnings CallApril 26, 2016 9:00 am ETExecutivesJohn C. Lechleiter - Chairman, President & Chief Executive OfficerPhilip Johnson - Vice President, Investor Relations,